Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials

Circulation

Volumn 96, Issue 4, 1997, Pages 1152-1156

  Fath Ordoubadi, Farzin ^a   Beatt, Kevin J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Glucose; Insulin; Meta analysis; Metabolism; Myocardial infarction

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030861078     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1152     Document Type: Article

References (55)

1. Sodi-Pallares D, Testelli MR, Fischleder BL. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol. 1962; 9:166-181.
2. Mittra B. Potassium, glucose, and insulin in treatment of myocardial infarction. Lancet. 1965;2:607-609.
3. Medical Research Council Working Party on the Treatment of Myocardial Infarction. Potassium, glucose, and insulin treatment for acute myocardial infarction. Lancet. 1968;2:1355-1360.
4. Lundman T, Orinius E. Insulin-glucose-potassium infusion in acute myocardial infarction. Acta Med Scand. 1965;178:525-528.
5. Sievers J, Lindh J, Johansson BW, Karnell J. Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion. Cardiology. 1966;49:239-247.
6. Autio L, Hakkila J, Hartel G, Ikkala E. Anticoagulants and SodiPallares infusion in acute myocardial infarction. Acta Med Scand. 1966;179:355-360.
7. Malach M. Polarizing solution in acute myocardial infarction. Am J Cardiol. 1967;20:363-366.
8. Pilcher J, Etishamudin M, Exon P, Moore J. Potassium, glucose and insulin in myocardial infarction. Lancet. 1967;1:1109.
9. Pentecost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet. 1968;1:946-948.
10. Iisalo E, Kallio V. Potassium, glucose and insulin in the treatment of acute myocardial infarction. Curr Ther Res Clin Exp. 1969;11: 209-215.
11. Hjermann I. A controlled study of peroral glucose, insulin and potassium treatment in myocardial infarction. Acta Med Scand. 1971;190:213-218.
12. Rogers WJ, Stanley AW, Breinig JB, Prather JW, McDaniel HG, Moraski RE, Mantle JA, Russell RO, Rackley CE. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J. 1976;92:441-454.
13. Heng MK, Norris RM. Singh BN, Barratt Boyes C. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. Br Heart J. 1977; 39:748-757.
14. Stanley AWH, Prather JW. Glucose-insulin-potassium, patient mortality and the acute myocardial infarction: results from a prospective randomized study. Circulation. 1978;57(suppl II):II-62. Abstract.
15. Rogers WJ, McDaniel HG, Mantle JA, Rackley CE. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction: effects of hemodynamics, short and long-term survival. J Am Coll Cardiol. 1983;1:628. Abstract.
16. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford, UK: Blackwell; 1987.
17. Bailey NTJ. Mathematics, Statistics and Systems for Health. New York, NY: Wiley; 1997.
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22: 719-748.
20. Satler LF, Green CE, Kent KM, Pallas RS, Pearle DL, Rackley CE. Metabolic support during coronary reperfusion. Am Heart J 1987; 114:54-58.
21. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L, on Behalf of the DIGAMI Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI): effect on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
22. Rackley CE, Russell RO, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J. 1981;102: 1038-1049.
23. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction: relation to myocardial ischemia and infarct size. Am J Cardiol. 1975;36:938-953.
24. Rogers WJ, McDaniel HG, Mantle JA, Russell RO, Rackley CE. Frontiers of therapy: use of glucose-insulin-potassium in treating myocardial infarction. J Cardiovasc Med. 1980;5:237-248.
25. Taegtmeyer H. Is there a rationale for glucose-insulin-potassium therapy in acute myocardial infarction? Cardiol Rev. 1995;26: 307-313.
26. Opie LH. The glucose hypothesis: relation to acute myocardial ischemia. J Mol Cell Cardiol. 1970;1:107-115.
27. Runnman EM, Weiss JN. Exogenous glucose utilization is superior to glycogenolysis at preserving cardiac function during hypoxia. Circulation. 1988;78(suppl II):II-261. Abstract.
28. Opie LH. Hypothesis: glycolytic rates control cell viability in ischemia. J Appl Cardiol. 1988;3:407-414.
29. Doorey AJ, Barry WH. The effects of inhibition of oxidative phosphorylation and glycolysis on contractility and high energy phosphate content in cultured chick heart cells. Circ Res. 1983;53: 192-201.
30. Hasin Y, Barry WH. Myocardial metabolic inhibition and membrane potential, contraction and potassium uptake. Am J Physiol. 1984;247: H322-H329.
31. ++ uptake in smooth muscle plasma membrane vesicles by an endogenous glycolytic cascade. FASEB J. 1989;3:2298-2301.
32. + channels in isolated guinea pig cardiac myocytes. Science. 1987; 238:67-69.
33. Opie LH, Tansey M, Kennelly BM. Proposed metabolic vicious circle in patients with large myocardial infarction and high plasma free fatty acid concentrations. Lancet. 1977;2:890-892.
34. Valori C, Thomas M, Shillingford J. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol. 1967;20:605.
35. Gupta DK, Jewitt DE, Young R. Increased plasma free fatty acid concentrations and their significance in patients with acute myocardial infarction. Lancet. 1969;2:1209.
36. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet. 1994;343:155-158.
37. Mjøs OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dog. J Clin Invest. 1971;50:1386.
38. Henderson AH, Most AS, Parmley WW. Depression of myocardial contractility in rats by free fatty acids during hypoxia. Circ Res. 1970;26:439.
39. Saman S, Coetzee WA, Opie LH. Inhibition by stimulated ischaemia or hypoxia of delayed after depolarizations provoked by cyclic AMP: significance for ischaemic and reperfusion arrhythmias. J Mol Cell Cardiol. 1988;20:91-95.
40. Oliver MF, Kurien VA, Greenwood TW. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968;1:710-714.
41. Kurien VA, Oliver MF. A metabolic cause of arrhythmias during acute myocardial hypoxia. Lancet. 1970;1:813-1815.
42. Kurien VA, Yates PA, Oliver MF. The role of free fatty acids in the production of ventricular arrhythmias after acute coronary occlusion. Eur J Clin Invest. 1971;1:225-241.
43. McDaniel HG, Papapietro SE, Rogers WJ, Mantle JA, Smith RL, Russell RO, Rackley CE. Glucose-insulin-potassium induced alterations in individual plasma free fatty acids in patients with acute myocardial infarction. Am Heart J. 1981;102:10-15.
44. Stanley AW, Moraski RE, Russell RO, Rogers WJ, Mantle JA, Kriesberg RA, McDaniel HG, Rackley CE. Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease: studies on myocardial carbohydrates, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease. Am J Cardiol. 1975;36: 929-937.
45. Vanoverschelde J-LJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol. 1994;267:H1785-H1794.
46. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res. 1991;68: 466-481.
47. Apstein CS, Deckelbaum L, Mueller M, Hagapian L, Hood WB. Graded global ischemia and reperfusion: cardiac function and lactate metabolism. Circulation. 1977;55:864-872.
48. Wildenthal K, Mierzwiak DS, Mitchell JH. Acute effects of increased serum osmolarity on left ventricular performance. Am J Physiol. 1969;216:898-904.
49. Davi G, Catalan I, Averna M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990;322: 1769-1774.
50. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycemic control. Diabetic Med. 1993;10:27-32.
51. Stanley A, Arciniegas J, Cooper T, Corley N, Hess R, MacLean W, Papapietro S. Glucose-insulin-potassium following successful coronary reperfusion improves survival during myocardial infarction). Circulation. 1984;70(suppl II):II-153. Abstract.
52. Rovetto MJ, Lamberton WF, Neely JR. Mechanism of glycolytic inhibition in ischemic rat heart. Circ Res. 1975;37:742-751.
53. Yusuf S, Flather M. Magnesium in acute myocardial infarction: ISIS 4 provides no grounds for its use. BMJ. 1995;310:751-752.
54. Egger M, Smith GD. Misleading meta-analysis: lessons from 'an effective, safe, simple' intervention that wasn't. BMJ. 1995;310: 752-754.
55. GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Micocardico). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397-401.